Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Dosing Interval, Efficacy, and Safety of SST-0225, a Topical Ibuprofen Cream, in the Treatment of Delayed Onset Muscle Soreness (DOMS)
Conditions
Interventions
SST-0225
Placebo
Locations
2
United States
Site #201
South Miami, Florida, United States
Site #202
Springfield, Missouri, United States
Start Date
November 1, 2014
Primary Completion Date
February 1, 2015
Completion Date
March 1, 2015
Last Updated
September 9, 2016
NCT06810271
NCT07438431
NCT05326893
NCT06535906
NCT06612502
NCT06076356
Lead Sponsor
Strategic Science & Technologies, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions